Arrhytmias and Cardiac Device treatment
1 – 10 of 75
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Prognostic utility and characterization of left ventricular hypertrophy using global thickness
(
- Contribution to journal › Article
-
Mark
Hemodynamic forces from 4D flow magnetic resonance imaging predict left ventricular remodeling following cardiac resynchronization therapy
(
- Contribution to journal › Article
-
Mark
Testosterone Level and Risk of Diabetes: Follow-Up Study
(
- Contribution to journal › Article
-
Mark
Hjärtspecialisten om ingreppet: ”Fungerar som en livförsäkring”
2023) In Sydsvenskan(
- Contribution to specialist publication or newspaper › Newspaper article
-
Mark
Sex‐based differences in cardiac resynchronization therapy upgrade and outcome for patients with pacemaker and new‐onset heart failure
(
- Contribution to journal › Article
-
Mark
Hjärtspecialist om ingreppet: "Fungerar som en livförsäkring"
2023) In Dagens Nyheter(
- Contribution to specialist publication or newspaper › Newspaper article
- 2022
-
Mark
Testosterone and coronary flow reserve: A study on Swedish men from the general population
(
- Contribution to journal › Article
-
Mark
Baseline QRS Area and Reduction in QRS Area Are Associated with Lower Mortality and Risk of Heart Failure Hospitalization after Cardiac Resynchronization Therapy
(
- Contribution to journal › Article
-
Mark
Repositioning and optimization of left ventricular lead position in non-responders to Cardiac Resynchronization Therapy is associated with improved ejection fraction, lower NT-ProBNP values and less heart failure symptoms
(
- Contribution to journal › Article
-
Mark
Diagnosis and treatment of the rare procedural complication of malpositioned pacing leads in the left heart: a single center experience
(
- Contribution to journal › Article